Recurrent Platinum Resistant Ovarian Cancer

specific

The reemergence of platinum-resistant ovarian carcinoma after a period of remission.

25

Centers

0

Active Trials

—

Cancer Funding

Top Centers for Recurrent Platinum Resistant Ovarian Cancer(25)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
52.0
2
Duke Cancer InstituteDurham, NC
NCI Comprehensive
52.0
3
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
52.0
4
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
52.0
5
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
52.0
6
UF Health Cancer InstituteGainesville, FL
NCI Clinical
52.0
7
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
52.0
8
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
52.0
9
Medical College of Wisconsin Cancer CenterMilwaukee, WI
52.0
10
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
52.0
11
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
52.0
12
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
52.0
13
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
52.0
14
University of Illinois Cancer CenterChicago, IL
52.0
15
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
52.0
16
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
52.0
17
Boston University Cancer CenterBoston, MA
52.0
18
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
52.0
19
Cancer Center at IllinoisUrbana, IL
52.0
20
Penn State Cancer InstituteHershey, PA
52.0
21
University of Cincinnati Cancer CenterCincinnati, OH
52.0
22
The University of Vermont Cancer CenterBurlington, VT
52.0
23
Northwell Health Cancer InstituteNew York, NY
52.0
24
Upstate Cancer CenterSyracuse, NY
52.0
25
Louisiana Cancer Research CenterNew Orleans, LA
52.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →